FDA Type 2a meeting scheduled for November 19, 2025, to review AEON’s analytical development plan and initial data - ...
Discover whether high-yield or dividend growth stocks offer better long-term returns. Click for more and a look at my strategy.
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...
Clinical Data—SIMPLIFY Study -- Updated analysis increased Gallery's PPV in symptomatic patients to 84.2% after long-term ...
Combined transactions will strengthen balance sheet and reduce outstanding debt by more than 90% - - $6 million PIPE financing with potential for over $7 million of additional capital via ...
Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to ...
The Google app for Search, and the Google office suite — Docs, Slides and Sheets — all run on iPhones. You can make or ...
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.
Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...
Good morning, ladies and gentlemen, and welcome to the Cellectar Biosciences' Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, November 13, 2025. I ...
This week, finished steel products fluctuated rangebound, while raw material prices diverged, with coking coal and coke showing relative weakness. Iron ore prices trended upward during the week, yet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback